Personal Information
Entreprise/Lieu de travail
Greater Seattle Area, WA United States
Profession
President & CEO at Myles Intellectual Property Law, PS
À propos
As a biotechnology patent attorney, Gary drafts and prosecutes patent applications for a broad range of life sciences inventions and develops intellectual property strategies for university, non-profit, start-up, and mid- and large-cap bio/pharma clients in the life sciences and agricultural industries. Gary also formulates freedom-to-operate, non-infringement and invalidity opinions and performs intellectual property due diligence reviews. His areas of technological expertise include molecular and cell biology, biochemistry, virology, cell biology, immunology, nanotechnology, and personalized medicine.
Gary's scientific experience includes post-doctoral research on the molecular mecha...
Mots-clés
prometheus
patents
patent
federal circuit
supreme court
biotechnology
myriad
35 usc 101
classen
bilski
dna
diagnostic methods
mayo
personalized medicine
nucleic acids
intellectual property
invention
35 usc 112 enablement written description
commil v. cisco
35 usc 271
induced infringement
scotus
patent eligibility
patent law
bio amicus brief commil v. cisco
corporate
limited liability companys
llc
corporations
corporate entity
startup
university of north carolina
aziz sancar
department of biochemistry
nobel prize in chemistry
nobel prize
school of medicine
103
novely
first to invent
102
written description
first inventor to file
112
first to file
america invents act
prior art
enablement
aia
law
non-obviousness
biochemistry
education
biophysics
law school
publications
legal experience
life sciences
board memberships
resume
science
gary myles
scientific experience
ph.d.
honors
curriculum vitae
incentive to innovate
cdna
eligibility
antibody
genomic
protein
gene
chakrabarty
law of nature
product of nature
in re kubin
patent office
amgen v. chugai
association of molecular pathology
myriad genetics
proteins
antibodies
claims
genes
laws of nature
cdnas
products of nature
commercial objectives
cost-effective
deals
value-added
start-up
financing
due diligence
product focus
Tout plus
Présentations
(16)Documents
(9)Personal Information
Entreprise/Lieu de travail
Greater Seattle Area, WA United States
Profession
President & CEO at Myles Intellectual Property Law, PS
À propos
As a biotechnology patent attorney, Gary drafts and prosecutes patent applications for a broad range of life sciences inventions and develops intellectual property strategies for university, non-profit, start-up, and mid- and large-cap bio/pharma clients in the life sciences and agricultural industries. Gary also formulates freedom-to-operate, non-infringement and invalidity opinions and performs intellectual property due diligence reviews. His areas of technological expertise include molecular and cell biology, biochemistry, virology, cell biology, immunology, nanotechnology, and personalized medicine.
Gary's scientific experience includes post-doctoral research on the molecular mecha...
Mots-clés
prometheus
patents
patent
federal circuit
supreme court
biotechnology
myriad
35 usc 101
classen
bilski
dna
diagnostic methods
mayo
personalized medicine
nucleic acids
intellectual property
invention
35 usc 112 enablement written description
commil v. cisco
35 usc 271
induced infringement
scotus
patent eligibility
patent law
bio amicus brief commil v. cisco
corporate
limited liability companys
llc
corporations
corporate entity
startup
university of north carolina
aziz sancar
department of biochemistry
nobel prize in chemistry
nobel prize
school of medicine
103
novely
first to invent
102
written description
first inventor to file
112
first to file
america invents act
prior art
enablement
aia
law
non-obviousness
biochemistry
education
biophysics
law school
publications
legal experience
life sciences
board memberships
resume
science
gary myles
scientific experience
ph.d.
honors
curriculum vitae
incentive to innovate
cdna
eligibility
antibody
genomic
protein
gene
chakrabarty
law of nature
product of nature
in re kubin
patent office
amgen v. chugai
association of molecular pathology
myriad genetics
proteins
antibodies
claims
genes
laws of nature
cdnas
products of nature
commercial objectives
cost-effective
deals
value-added
start-up
financing
due diligence
product focus
Tout plus